1094 related articles for article (PubMed ID: 9640413)
21. Differential effects of estrogen treatment on bone mineral density of the spine, hip, wrist and total body in late postmenopausal women.
Kohrt WM; Birge SJ
Osteoporos Int; 1995 May; 5(3):150-5. PubMed ID: 7655174
[TBL] [Abstract][Full Text] [Related]
22. A longitudinal study of supine lateral DXA of the lumbar spine: a comparison with posteroanterior spine, hip and total-body DXA.
Blake GM; Herd RJ; Fogelman I
Osteoporos Int; 1996; 6(6):462-70. PubMed ID: 9116392
[TBL] [Abstract][Full Text] [Related]
23. Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency.
Johannsson G; Rosén T; Bosaeus I; Sjöström L; Bengtsson BA
J Clin Endocrinol Metab; 1996 Aug; 81(8):2865-73. PubMed ID: 8768843
[TBL] [Abstract][Full Text] [Related]
24. Effects on bone mass after eight years of hormonal replacement therapy.
Eiken P; Nielsen SP; Kolthoff N
Br J Obstet Gynaecol; 1997 Jun; 104(6):702-7. PubMed ID: 9197874
[TBL] [Abstract][Full Text] [Related]
25. Bone mineral density of the spine and femur in healthy Saudi females: relation to vitamin D status, pregnancy, and lactation.
Ghannam NN; Hammami MM; Bakheet SM; Khan BA
Calcif Tissue Int; 1999 Jul; 65(1):23-8. PubMed ID: 10369729
[TBL] [Abstract][Full Text] [Related]
26. Effects of long-term treatment with GH in the bone mineral density of adults with hypopituitarism and GH deficiency and after discontinuation of GH replacement.
Gómez JM; Gómez N; Fiter J; Soler J
Horm Metab Res; 2000 Feb; 32(2):66-70. PubMed ID: 10741688
[TBL] [Abstract][Full Text] [Related]
27. Dual X-ray absorptiometry: cross-calibration of a new fan-beam system.
Blake GM; Harrison EJ; Adams JE
Calcif Tissue Int; 2004 Jul; 75(1):7-14. PubMed ID: 15037973
[TBL] [Abstract][Full Text] [Related]
28. [Long-term effects of 7-year growth hormone substitution on bone metabolism, bone density, and bone quality in growth hormone-deficient adults].
Wilhelm B; Kann PH
Med Klin (Munich); 2004 Oct; 99(10):569-77. PubMed ID: 15490072
[TBL] [Abstract][Full Text] [Related]
29. Bone mineral density and circulating cytokines in patients with acromegaly.
Longobardi S; Di Somma C; Di Rella F; Angelillo N; Ferone D; Colao A; Merola B; Lombardi G
J Endocrinol Invest; 1998 Nov; 21(10):688-93. PubMed ID: 9854685
[TBL] [Abstract][Full Text] [Related]
30. The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: longitudinal evaluation and response to intermittent cyclic etidronate therapy.
Diamond T; Campbell J; Bryant C; Lynch W
Cancer; 1998 Oct; 83(8):1561-6. PubMed ID: 9781950
[TBL] [Abstract][Full Text] [Related]
31. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women.
Holloway L; Kohlmeier L; Kent K; Marcus R
J Clin Endocrinol Metab; 1997 Apr; 82(4):1111-7. PubMed ID: 9100582
[TBL] [Abstract][Full Text] [Related]
32. A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetate.
Cundy T; Ames R; Horne A; Clearwater J; Roberts H; Gamble G; Reid IR
J Clin Endocrinol Metab; 2003 Jan; 88(1):78-81. PubMed ID: 12519833
[TBL] [Abstract][Full Text] [Related]
33. Bone mineral density in normal Swedish women.
Löfman O; Larsson L; Ross I; Toss G; Berglund K
Bone; 1997 Feb; 20(2):167-74. PubMed ID: 9028542
[TBL] [Abstract][Full Text] [Related]
34. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.
Thorén M; Hilding A; Brismar T; Magnusson P; Degerblad M; Larsson L; Sääf M; Baylink DJ; Mohan S
J Bone Miner Res; 1998 May; 13(5):891-9. PubMed ID: 9610754
[TBL] [Abstract][Full Text] [Related]
35. The accuracy of bone mineral density at distal radius on non-forearm osteoporosis identification.
Trivitayaratana W; Trivitayaratana P
J Med Assoc Thai; 2001 Apr; 84(4):566-71. PubMed ID: 11460970
[TBL] [Abstract][Full Text] [Related]
36. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.
Biermasz NR; Hamdy NA; Pereira AM; Romijn JA; Roelfsema F
Clin Endocrinol (Oxf); 2004 May; 60(5):568-75. PubMed ID: 15104559
[TBL] [Abstract][Full Text] [Related]
37. Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency.
Götherström G; Bengtsson BA; Bosaeus I; Johannsson G; Svensson J
Eur J Endocrinol; 2007 Jan; 156(1):55-64. PubMed ID: 17218726
[TBL] [Abstract][Full Text] [Related]
38. Further increase in forearm cortical bone mineral content after discontinuation of growth hormone replacement.
Holmes SJ; Whitehouse RW; Economou G; O'Halloran DJ; Adams JE; Shalet SM
Clin Endocrinol (Oxf); 1995 Jan; 42(1):3-7. PubMed ID: 7889628
[TBL] [Abstract][Full Text] [Related]
39. [Bone mineral density investigation of normal women in Changsha by dual energy X-ray absorptiometry and its clinical implications].
Wang W; Liao E; Deng X
Zhonghua Fu Chan Ke Za Zhi; 1999 Feb; 34(2):74-7. PubMed ID: 11263201
[TBL] [Abstract][Full Text] [Related]
40. Adequacy of androgen replacement influences bone density response to testosterone in androgen-deficient men.
Aminorroaya A; Kelleher S; Conway AJ; Ly LP; Handelsman DJ
Eur J Endocrinol; 2005 Jun; 152(6):881-6. PubMed ID: 15941928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
